Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Card Fail. 2018 Oct 6;24(11):753–762. doi: 10.1016/j.cardfail.2018.09.015

Table 4.

Incremental Value of Resting HR and CIx in Predicting Adverse Clinical Events Beyond Clinical Variables

Factors C-Statistic (95% CI) without CIx C-Statistic (95% CI) with CIx P Value NRI (95% CI) for Composite Events at 2 y P Value IDI (95% CI) for Composite Events at 2 y P Value
Clinical + resting HR 0.72 (0.68–0.76) 0.76 (0.72–0.79) .005 27.0% (10.2%–37.0%) <.001 4.2% (1.5%–8.5%) .008
Clinical + resting HR + peak VO2 0.76 (0.72–0.79) 0.77 (0.73–0.80) .16 15.2% (0.6%–28.9%) .024 1.2% (−0.2% to 3.7%) .12

Clinical variables: age, sex, cardiomyopathy etiology, diabetes, LVEF, β-blocker use, presence of CRT/ICD, eGFR. IDI, integrated discrimination improvement; NRI, net reclassification improvement; other abbreviations as in Table 1.